Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 13, 2020
Metabolism and <i>in vitro</i> drug-drug interaction assessment of viloxazineChungping YuJournal of Experimental Pharmacology|December 13, 2018
In vitro pharmacological characterization of SPN-810M (molindone)Chungping Yu, Gopakumar GopalakrishnanBirth Defects Research|September 20, 2018
Reproductive toxicology studies supporting the safety of molindone, a dopamine receptor antagonistGopakumar Gopalakrishnan, Shivaputhrappa Ganiger, Tacey E K White, et al.Journal of Experimental Pharmacology|September 18, 2020
New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating PropertiesChungping Yu, Jennie Garcia-Olivares, Shawn Candler, et al.Drugs in R&D|April 3, 2026
Updated Viloxazine Pharmacology: Experiments Establish Norepinephrine Transporter Occupancy and Serotonin 5-HT<sub>2C</sub>, 5-HT<sub>2B</sub>, and 5-HT<sub>7</sub> Receptor Binding at Therapeutically Relevant ConcentrationsJennie Garcia-Olivares, Brittney Yegla, Jennifer Koch, et al.Rapid Communications in Mass Spectrometry : RCM|January 16, 2007
A rapid method for quantitatively estimating metabolites in human plasma in the absence of synthetic standards using a combination of liquid chromatography/mass spectrometry and radiometric detectionChungping Yu, Cathy L Chen, Frances L Gorycki, et al.Journal of Experimental Pharmacology|January 22, 2024
Viloxazine Increases Extracellular Concentrations of Norepinephrine, Dopamine, and Serotonin in the Rat Prefrontal Cortex at Doses Relevant for the Treatment of Attention-Deficit/Hyperactivity DisorderJennie Garcia-Olivares, Brittney Yegla, Frank P Bymaster, et al.Epilepsia Open|August 3, 2024
Huperzine A suppresses absence seizures in the genetic absence epilepsy rat from Strasbourg (GAERS) model of genetic generalized epilepsy with absence seizuresPablo M Casillas-Espinosa, Jennie Garcia-Olivares, Rui Li, et al.Postgraduate Medicine|January 26, 2019
A proposed anti-maladaptive aggression agent classification: improving our approach to treating impulsive aggressionAdelaide S Robb, Stefan Schwabe, Gianpiera Ceresoli-Borroni, et al.CNS Drugs|May 18, 2021
Viloxazine in the Management of CNS Disorders: A Historical Overview and Current StatusRobert L Findling, Shawn A Candler, Azmi F Nasser, et al.Pageof 2